EPS: US$0.22 (up from US$0.18 in 2Q 2023). Revenue exceeded analyst estimates by 2.5%. Earnings per share (EPS) missed analyst estimates by 39%. Looking ahead, revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 8.3% growth forecast for the Medical Equipment industry in the US.
Original Image Link
Source:finance.yahoo.com
Original Image Link
Source:finance.yahoo.com
Posted: 2024-07-26 03:58:00